alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# In the United States Court of Federal Claims
OFFICE OF SPECIAL MAST ERS No. 20-0569V UNPUBLISHED

RENE VILLA, Petitioner, v. SECRETARY OF HEALTH AND HUMAN SERVICES, Respondent. Chief Special Master Corcoran Filed: August 2, 2021 Specia l Processing Unit (SPU); Ruling on Entitlement; Concession; Table Injury; Influenza (Flu) Vaccine; Shoulder Injury Related to Vaccine Administration (SIRVA)

Ronald Craig Homer, Conway, Homer, P.C., Boston, MA, for Petitioner. Sarah Black Rifkin, U.S. Department of Ju stice, Washington, DC, for Respondent.
RULING ON ENTITLEMENT 1 On May 7, 2020, Rene Villa filed a petit ion for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq. 2 (the “Vaccine Act”). Petitioner alleges that he received an influenza (“flu”) vaccination on October 13, 2018, and, thereafter, suffer ed a left-sided shoulder injury related to vaccine administration (“SIRVA”). Petition at 1-2. The case was assigned to the Special Processing Unit of the Offi ce of Special Masters. On August 2, 2021, Responden t filed his Rule 4(c) report in which he concedes that Petitioner is entitled to compensation in this case. Respondent’ s Rule 4(c) Report at 1. Specifically, Respondent states that Petiti oner “had no history of pain, inflammation or dysfunction in his left shoulder; his pain occurred within 48 hours of receipt of an

1 Because this unpublished ruling contains a reasoned explanation for the action in this case, I am required to post it on the United States Court of Federal Claims ' website in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). This means the ruling will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would cons titute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access.

2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). CORRECTED2 intramuscular vaccination; his pain and reduc ed range of motion were limited to the shoulder in which the vaccine was administe red; and no other condition or abnormality was identified to explain his symptoms. Id. at 6. Respondent further agrees that the six month sequela requirement has been satisfied and that Petiti oner has therefore satisfied all legal prerequisites for com pensation under the Vaccine Act. Id. In view of Respondent’s position a nd the evidence of record, I find that Petitioner is entitled to compensation.
IT IS SO ORDERED.
s/Brian H. Corcoran Brian H. Corcoran Chief Special Master
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                                          <C>
<PERIOD-TYPE>                                3-MOS
<FISCAL-YEAR-END>                          JUN-30-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                             282
<SECURITIES>                                         0
<RECEIVABLES>                                    5,861
<ALLOWANCES>                                         0
<INVENTORY>                                      4,247
<CURRENT-ASSETS>                                10,535
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  10,535
<CURRENT-LIABILITIES>                          137,778
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        41,733
<OTHER-SE>                                   (168,976)
<TOTAL-LIABILITY-AND-EQUITY>                    10,535
<SALES>                                          4,998
<TOTAL-REVENUES>                                 4,998
<CGS>                                                0
<TOTAL-COSTS>                                      192
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                  4,806
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                              4,806
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                  1,990
<CHANGES>                                            0
<NET-INCOME>                                     6,796
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        




</TABLE>
Michigan Supreme Court

Lansing, Michigan

Stephen J. Markman

, Chief Justice

Robert P. Young, Jr.

Brian K. Zahra

Bridget M. McCormack

David F. Viviano

Richard H. Bernstein

Joan L. Larsen,

Justices

I, Larry S. Royster , Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

January 31, 2017

s0123 

# Order

Clerk January 31, 2017

153694 & (67)

PEOPLE OF THE STATE OF MICHIGAN,

Plaintiff

- Appellee,

v SC: 153694

COA: 325192

Ionia CC: 2014

- 015993

- FH

KYLE BRANDON RICHARDS,

Defendant

- Appellant.

_________________________________________/

On order of the Court, the motion to supplement application for leave to appeal is

GRANTED. The application for leave to appeal the April 26, 2016 judgment of the

Court of Appeals is considered, and it appearing to this Court that the cases of People v

St eanhouse (Docket No. 152849) and People v Masroor (Docket Nos. 152946

- 8) are

pending on appeal before this Court and that the decisions in those cases may resolve an

issue raised in the present application for leave to appeal, we ORDER that the application

be held in ABEYANCE pending the decisions in those cases.
## Appendix 10.13

Reference 14:

Faggert, Pamela F. of Dominion Resources Services, Inc., Concerning the Memorandum of Understanding on SO 2 and NO

x Reductions Reflective of BART for Kincaid Units 1 and 2, to Ja mes R. Ross of the Illinois Environmental Protection Agency, February 3, 2009.
D.L., Appellant/Petitioner(s), v. DEPT. OF CHILDREN & FAMILIES, Appellee/Respondent(s).

CASE NO.: 2D16-5213

District Court of Appeal of Florida, Second District.

April 20, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Dismissed.
Exhibit 32.1

Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Annual Report of Avantair, Inc., a Delaware corporation (the Company), on Form 10-K for the period ended June 30, 2011 as filed with the Securities and Exchange
Commission on the date hereof (the Report), I, Steven Santo, Chief Executive Officer (principal executive officer) of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) the Report fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly
presents, in all material respects, the financial condition and results of operations of the Company.

Date: September 23, 2011



|                 |  |                        
|---------------- |  | -----------------------
|/s/ Steven Santo
|Name:            |  | Steven Santo           
|Title:           |  | Chief Executive Officer
CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the amended Annual Report of Cardero Resource Corp. (the Company) on Form 40-F for the year ended October 31, 2007 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Henk Van Alphen, the President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date:  January 30, 2008



/s/ Henk Van Alphen

Henk Van Alphen
President and Chief Executive Officer
II 

112TH CONGRESS 

2D SESSION S. 2744 

To renew the temporary suspension of duty on europium oxide. 

IN THE SENATE OF THE UNITED STATES 

MAY 7, 2012 

Mr. CASEY introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To renew the temporary suspension of duty on europium 

oxide. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. EUROPIUM OXIDE. 

4 (a) IN GENERAL.—Heading 9902.02.22 of the Har5 monized Tariff Schedule of the United States (relating to 

6 europium oxide) is amended by striking the date in the 

7 effective period column and inserting ‘‘12/31/2015’’. 

8 (b) EFFECTIVE DATE.—The amendment made by 

9 subsection (a) applies to goods entered, or withdrawn from 


rfrederick on DSK6VPTVN1PROD with BILLS
2 

•S 2744 IS

1 warehouse for consumption, on or after the 15th day after 

2 the date of the enactment of this Act. 

Æ 


rfrederick on DSK6VPTVN1PROD with BILLS
Bryan Jason KONECNY, DOC #Y38404, Appellant, v. STATE of Florida, Appellee.

Case Nos. 2D16-4170 2D16-4172 CONSOLIDATED

District Court of Appeal of Florida, Second District.

Opinion filed December 27, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
**EXHIBIT 31.2**

**CERTIFICATIONS**

I, Craig R. Ramsey,certify that:

1.                 I have reviewedthis amended annual report on Form 10-K/A of Marquee Holdings Inc.;

2.                 Based on myknowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, inlight of the circumstances under which such statements were made, notmisleading with respect to the period covered by this report;

3.                 Based on myknowledge, the financial statements, and other financial information includedin this report, fairly present in all material respects the financialcondition, results of operations and cash flows of the registrant as of, andfor, the periods presented in this report;

4.                 The registrant’sother certifying officer and I are responsible for establishing and maintainingdisclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have:

a)               Designed suchdisclosure controls and procedures, or caused such disclosure controls and proceduresto be designed under our supervision, to ensure that material informationrelating to the registrant, including its consolidated subsidiaries, is madeknown to us by others within those entities, particularly during the period inwhich this report is being prepared;

b)              Evaluated theeffectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and

c)               Disclosed in thisreport any change in the registrant’s internal control over financial reportingthat occurred during the registrant’s most recent fiscal quarter (theregistrant’s fourth fiscal quarter in the case of an annual report) that hasmaterially affected, or is reasonable likely to materially affect, theregistrant’s internal control over financial reporting; and

5.                 The registrant’sother certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’sauditors and the audit committee of registrant’s board of directors (or personsperforming the equivalent functions):

a)               All significantdeficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adverselyaffect the registrant’s ability to record, process, summarize and reportfinancial information; and

b)              Anyfraud, whether or not material, that involves management or other employees whohave a significant role in the registrant’s internal control over financialreporting.
| Date: April 16, 2007 |   | /s/ CRAIG R.  RAMSEY                                                   |
|----------------------|--------|------------------------------------------------------------------------|
|                      |   | Craig R. Ramsey  Executive Vice President and  Chief Financial Officer |

 

----
II 

112TH CONGRESS 

2D SESSION S. 2597 

To extend the temporary suspension of duty on benzene, 2,4-dichloro-1,3- 

dinitro-5-(trifluoromethyl). 

IN THE SENATE OF THE UNITED STATES 

MAY 7, 2012 

Mr. CARPER (for himself and Mr. COONS) introduced the following bill; which 

was read twice and referred to the Committee on Finance 

A BILL 

To extend the temporary suspension of duty on benzene, 

2,4-dichloro-1,3-dinitro-5-(trifluoromethyl). 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. BENZENE, 2,4-DICHLORO-1,3-DINITRO-5- 

4 (TRIFLUOROMETHYL). 

5 (a) IN GENERAL.—Heading 9902.40.56 of the Har6 monized Tariff Schedule of the United States (relating to 

7 benzene, 2,4-dichloro-1,3-dinitro-5-(trifluoromethyl)) is 

8 amended by striking the date in the effective period col9 umn and inserting ‘‘12/31/2015’’. 


jbell on DSK7SPTVN1PROD with BILLS
2 

•S 2597 IS

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies with respect to goods entered, or 

3 withdrawn from warehouse for consumption, on or after 

4 the 15th day after the date of the enactment of this Act. 

Æ 


jbell on DSK7SPTVN1PROD with BILLS
Exhibit 13.2


CERTIFICATION PURSUANT TO


18 U.S.C. §1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In
connection with the Annual Report on Form 20-F for the fiscal year
ended June 30, 2020 of NextSource Materials Inc. (the "Company"),
the undersigned, in the capacity and on the date indicated below,
hereby certifies pursuant to 18 U.S.C. § 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:





(1)           The
Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934, as amended;
and





(2)           The
information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations
of the Company.





Date:
December 4, 2020








By:
/s/
Marc JohnsonMarc
JohnsonChief Financial Officer(principal accounting officer)
II 

112TH CONGRESS 

2D SESSION S. 2678 

To suspend temporarily the duty on 1,2,4 Triazole. 

IN THE SENATE OF THE UNITED STATES 

MAY 7, 2012 

Mr. CASEY introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To suspend temporarily the duty on 1,2,4 Triazole. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. 1,2,4 TRIAZOLE. 

4 (a) IN GENERAL.—Subchapter II of chapter 99 of 

5 the Harmonized Tariff Schedule of the United States is 

6 amended by inserting in numerical sequence the following 

7 new heading: 

‘‘ 9902.01.00 1H-[1,2,4]Triazole (CAS No. 

288–88–0) (provided for in 

subheading 2933.99.97) ........ Free No change No change On or before 

12/31/2015 ’’. 

8 (b) EFFECTIVE DATE.—The amendment made by 

9 subsection (a) applies with respect to goods entered, or 


rfrederick on DSK6VPTVN1PROD with BILLS
2 

•S 2678 IS

1 withdrawn from warehouse for consumption, on or after 

2 the 15th day after the date of the enactment of this Act. 

Æ 


rfrederick on DSK6VPTVN1PROD with BILLS
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2478 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2478

To extend the temporary suspension of duty on 4,8-dicyclohexyl -6-2,10-
           dimethyl -12H-dibenzo[d,g][1,3,2]-dioxaphosphocin.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             April 26, 2012

 Mr. Brown of Ohio introduced the following bill; which was read twice 
                and referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
To extend the temporary suspension of duty on 4,8-dicyclohexyl -6-2,10-
           dimethyl -12H-dibenzo[d,g][1,3,2]-dioxaphosphocin.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. 4,8-DICYCLOHEXYL -6-2,10-DIMETHYL -12H-DIBENZO[D,G][1,3,2]-
              DIOXAPHOSPHOCIN.

    (a) In General.--Heading 9902.12.77 of the Harmonized Tariff 
Schedule of the United States (relating to 4,8-dicyclohexyl -6-2,10-
dimethyl -12H-dibenzo[d,g][1,3,2]-dioxaphosphocin) is amended by 
striking the date in the effective period column and inserting ``12/31/
2015''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY INFORMATION EXTRACTED FROM
THE QUARTERLY REPORT ON FORM 10-Q FOR THE SIX MONTHS ENDED
JUNE 30, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH QUARTERLY REPORT ON FORM 10-Q.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                           7,234
<SECURITIES>                                   118,484
<RECEIVABLES>                                   25,450
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 151,168
<CURRENT-LIABILITIES>                            8,346
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                     142,822
<TOTAL-LIABILITY-AND-EQUITY>                   151,168
<SALES>                                              0
<TOTAL-REVENUES>                                 6,939
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                   982
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                  5,957
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                              5,957
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     5,957
<EPS-BASIC>                                      .47
<EPS-DILUTED>                                        0



</TABLE>
FILED

U.S. COURT OF APPEALS

ELEVENTH CIRCUIT

AUGUST 13, 2010

JOHN LEY

 CLERK

[DO NOT PUBLISH]

 IN THE UNITED STATES COURT OF APPEALS

 FOR THE ELEVENTH CIRCUIT

 ________________________

 No. 10-11423 

Non-Argument Calendar

 ________________________

 D.C. Docket No. 1:09-cv-00717-TCB

VIAVIENTE TAIWAN, LP,

lllllllllllllllllllllPlaintiff-Counter-Defendant-Appellant,

 versus

UNITED PARCEL SERVICE, INC.,

lllllllllllllllllllllDefendant-Counter-Claimant-Appellee.

________________________

 Appeal from the United States District Court

 for the Northern District of Georgia

 ________________________

(August 13, 2010)

Before EDMONDSON, HULL and MARTIN, Circuit Judges.

PER CURIAM:

After review of the briefs and record in this appeal, the Court affirms the

district court’s orders, dated March 3, 2010 and April 13, 2010, which collectively
(1) declared that plaintiff VieViente Taiwan, LP (“ViaViente”) is contractually

obligated to indemnify defendant United Parcel Service, Inc. (“UPS”) for all

duties, taxes, penalties, and fines assessed by Taiwan customs authorities in

connection with shipments of ViaViente products to Taiwan, and (2) granted

summary judgment in favor of defendant UPS on plaintiff ViaViente’s complaint

and on UPS’s counterclaims. We also affirm the district court’s entry of an

amended judgment in favor of UPS in the amount of $2,821.49 against ViaViente,

for the reasons outlined in the district court’s thorough and well-reasoned order of

March 3, 2010. 

AFFIRMED.

2
IN THE SUPREME COURT OF PENNSYLVANIA

MIDDLE DISTRICT

COMMONWEALTH OF PENNSYLVANIA,

Respondent

v.

RICKEY CHARLES WILSON,

Petitioner

:

:

:

:

:

:

:

:

:

:

:

No. 728 MAL 2020

Petition for Allowance of Appeal 

from the Order of the Superior Court

ORDER

PER CURIAM

AND NOW, this 16th day of March, 2021, the Petition for Allowance of Appeal is 

DENIED.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Labor

###### Employment and Training Administration

          - [TA-W-65,320]

Pursuant to Section 221 of the Trade Act of 1974, as amended, an investigation was initiated on February 20, 2009 in response to a petition filed by the International Association of Machinists and Aerospace Workers, Local 24, on behalf of the workers of Auto Truck Transport, Portland, Oregon.

The petitioner requested that the petition be withdrawn. Consequently, the investigation has been terminated.

Signed at Washington, DC, this 27th day of March 2009.

Richard Church,

Certifying Officer, Division of Trade Adjustment Assistance.

[FR Doc. E9-8926 Filed 4-17-09; 8:45 am]

BILLING CODE 4510-FN-P